Ask five state regulators to define a “pre-roll” and you’ll get five different answers. In California, it’s any combination of flower, shake, leaf, or kief rolled in paper. In Oklahoma, a “non-infused pre-roll” must consist only of flower, shake, or trim with unflavored paper, a filter, tip, or cone. In New York, the Office of Cannabis Management tracks “Raw Pre-Rolls” and “Infused or Enhanced Pre-Rolls” as entirely separate product categories under different METRC. And in Ohio, pre-rolls didn’t exist as a legal product category at all until regulators introduced “single serving units” in 2025.
For consumers, none of this matters. For manufacturers operating in a $4 billion category—with pre-rolls now the fourth-most-popular product type in U.S. cannabis—this patchwork of definitions is one of the most underappreciated operational risks in the industry.
Same Product, Different Rules
The concept seems simple: ground cannabis, rolled in paper, ready to smoke. But regulators disagree on fundamental questions. Is rolling flower into a cone a “manufacturing” activity? Does adding kief make it “infused”? Can a cultivator roll their own flower, or must a licensed processor handle it?
California is instructive. The state explicitly excludes non-infused pre-roll preparation by distributors from the definition of “manufacture”. But the moment a distributor adds distillate or live resin, they’ve crossed into manufacturing territory and need a different license. Meanwhile, California defines “infused pre-roll” as one containing concentrate other than kief—so a kief-dusted joint is still a standard pre-roll. In other states, any added cannabinoid material beyond flower triggers the infused classification, with different testing, labeling, and licensing requirements.
Ohio took yet another approach. When the Division of Cannabis Control finally permitted pre-rolls, it imposed strict weight limits (one gram per unit for raw, five-unit package caps) and mandated that only licensed processors could manufacture them. For a multi-state operator accustomed to producing two-gram king-size cones in Colorado, entering Ohio means re-engineering SKUs from the ground up.
The “Manufacturing” Trigger
Whether rolling a cone counts as “manufacturing” or “packaging” determines which license you need, what facility standards apply, and what testing your product must pass. In some states, it’s a low-burden packaging activity. In others, the same physical act triggers GMP-aligned requirements: documented SOPs, sanitation protocols, batch records, and quality checks for weight, moisture, and consistency.
Ohio’s recent finalization of GMP requirements under OAC 1301:18-4-01 makes this shift explicit. Beginning in 2026, processors producing pre-rolls must meet standards aligned with federally recognized manufacturing. As mg Magazine reported, this moves pre-roll production from “assembly” to true manufacturing. A lean operation designed for speed and throughput may suddenly need environmental controls, training programs, and documentation systems—capital investments that weren’t in the original budget.
The Infusion Line: Where It Gets Expensive
This is more than academic. Infused pre-rolls are the fastest-growing sub-segment of the category, reaching 44.4% of pre-roll market share in the first half of 2024, up from 34.4% on average since 2019. They command premium price points and protect margins in price-compressed markets. But the boundary between “standard” and “infused” varies state to state, and crossing that line changes everything: your product’s regulatory identity, its tracking category, your testing obligations, and potentially the license required to produce it.
A single SKU—say, a one-gram pre-roll with a kief dusting—might be classified as a standard pre-roll in California, an infused product in another state, and something that doesn’t fit any existing category in a third. Multiply that across a dozen SKUs and six active markets, and regulatory overhead becomes a serious drag on margins.
Stranded Inventory Is the Real Cost
When definitions shift, the consequences cascade fast. Product SKUs get pulled. Inventory becomes stranded. Labels must be redesigned. Testing protocols must be updated. In worst cases, finished product sitting in packaging must be destroyed.
The federal hemp landscape illustrates this at scale. The Continuing Appropriations and Extensions Act of 2026 shifted the definition of hemp from a delta-9-only standard to a total THC metric with a 0.4mg per-container cap, effective November 2026. Industry attorneys have warned that significant volumes of compliant hemp material may have no viable buyer before the rules take effect—commercially stranded not because of quality issues, but because the definition changed underneath the people who made it.
The same dynamic plays out every time a state tightens a pre-roll definition or reclassifies a product type. The losses are real: wasted material, idle capacity, rush-ordered packaging, expedited testing fees, and time spent on compliance firefighting instead of building a business
Arkansas and the Broader Patchwork
Arkansas offers a particularly instructive example of how regulatory language can inadvertently constrain a market. The state’s medical marijuana framework was built around cultivation facilities and dispensaries, with manufacturing and processing rules crafted primarily with concentrates and edibles in mind. Pre-rolls occupy an awkward middle ground in this structure: they’re not flower in its raw form, but they’re not a manufactured concentrate either. The result is a regulatory environment where operators must interpret rules that weren’t written with their specific product in mind and hope their interpretation aligns with the regulator’s.
Arkansas is far from alone. Across the country, pre-roll manufacturers face a recurring pattern: regulations written for an earlier era of the industry that haven’t kept pace with how the category has evolved. The U.S. pre-roll market reached approximately $3.1 billion in 2024, with Americans purchasing more than 316 million units that year. By 2025, the category had grown to an estimated $4 billion in sales, ranking as the fourth-most-popular product type nationally. The scale of the category has outgrown the regulatory infrastructure designed to govern it.
What Smart Operators Are Doing
The manufacturers managing this best share a few traits. They treat regulatory intelligence as a core function—tracking not just current rules but draft language and enforcement patterns. They design production lines for flexibility over pure throughput, because a line that can accommodate different weight specs and packaging configurations without a full retool is worth more than one that runs faster but only produces one SKU profile.
They build compliance buffers into their supply chain: sourcing cones from distributors with same-day invoicing and rapid fulfillment, so a production pivot doesn’t become a shutdown. And they’re investing in GMP readiness now, even where it isn’t yet required. Ohio’s GMP mandate is a preview, not an anomaly. As regulators increasingly view pre-rolls through a manufacturing lens, operators with documented SOPs and batch traceability in place will absorb new requirements without disruption.
The Path Forward
Regulatory harmonization across state cannabis markets remains a distant goal. The federal government has taken steps toward a more coherent framework—the updated Farm Bill’s shift to total THC standards, the Executive Order directing agencies to develop unified hemp cannabinoid rules, and the anticipated rescheduling of cannabis to Schedule III—but none of these actions will produce uniform pre-roll definitions at the state level. States will continue to write their own rules, and those rules will continue to diverge on the details that matter most to manufacturers.
In this environment, the manufacturers who thrive will be the ones who accept definitional ambiguity as a permanent feature of the landscape rather than a temporary inconvenience. They will build organizations capable of tracking, interpreting, and adapting to regulatory changes across multiple jurisdictions simultaneously. They will invest in flexible production infrastructure and reliable supply chain partnerships. And they will approach compliance not as a cost center to minimize, but as an operational capability that protects revenue and enables growth.
The pre-roll is the simplest product in cannabis. The regulatory environment surrounding it is anything but. The gap between those two realities is where margin lives—and where margin dies.
Green Blazer is a verified RAWthentic partner and one of the top national suppliers of bulk RAW pre-rolled cones, serving over 100 licensed pre-roll manufacturers, co-packaging facilities, and commercial growers. With fulfillment centers in Nevada and Indiana, same-day invoicing, and a price-match guarantee, Green Blazer delivers the supply chain reliability that pre-roll operations need to stay ahead of regulatory shifts.
